The most common innovation failure in established companies is not a lack of ideas — it is an organizational immune system that systematically kills promising innovations before they can demonstrate their potential.
The Portfolio Governance Approach
The companies that maintain consistent innovation output treat their innovation investments as a portfolio rather than a series of individual bets. This means maintaining a defined allocation to exploration-stage innovation — typically 10-20% of the total innovation budget — that is explicitly protected from the quarterly performance pressures that govern the core business. The CEO’s role in innovation governance is to protect this allocation during the periods when it would be most tempting to redirect it to short-term performance, which is precisely when the innovation pipeline is most vulnerable.
The Metrics Mismatch Problem
Most organizations apply the same performance metrics to innovation investments that they apply to the core business — which systematically penalizes early-stage innovation for failing to meet standards that are not appropriate for its stage of development. The solution is a stage-gated measurement system that applies different success criteria at different stages: learning metrics at the exploration stage, proof-of-concept metrics at the validation stage, and financial performance metrics only after the innovation has been validated and is being scaled.
